NICE (National Institute for Health and Clinical Excellence) tackles age and lifestyle in NHS access policies
This article was originally published in Clinica
The National Institute for Health and Clinical Excellence (NICE) has published draft guidelines on the social value judgements that impinge on the development of its guidance. The final document will, together with scientific considerations, feed into its own assessment processes, and will not in itself constitute guidance to the wider NHS.
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.